LASSBio-1135

N/A

Report date: 2023/11/17 09:30:39
NME

Base Information

Drug NameLASSBio-1135
Drug Alias NameLASSBio-1135
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitorsVanilloid receptor antagonistsTumor necrosis factor α inhibitors
TargetsCyclooxygenase-2Transient receptor potential cation channel subfamily V member 1Tumor necrosis factor α
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFederal University of Rio de Janeiro
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFederal University of Rio de Janeiro
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A